A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer
- Luis Paz-Ares
- , Beatrix Bálint
- , Richard H. De Boer
- , Jan P. Van Meerbeeck
- , Rafal Wierzbicki
- , Paul De Souza
- , Francesco Galimi
- , Vincent Haddad
- , Tony Sabin
- , Yong-jiang Hei
- , Yang Pan
- , Susan Cottrell
- , Cheng-Pang Hsu
- , Rodryg RamLau
Research output: Contribution to journal › Article › peer-review
66
Citations
(Scopus)